New research from Oregon Health & Science University (OHSU) reveals a troubling link between the loss of health insurance and deteriorating outcomes for patients with diabetes, especially those from low-income backgrounds. Published in the peer-reviewed journal JAMA Health Forum, the study meticulously analyzed electronic health records from more than 39,000 adults receiving care at community health centers across 20 states, uncovering that interruptions in coverage—commonly known as insurance “churn”—result in worse glycemic control and a greater reliance on intensive diabetes therapies.
The phenomenon of insurance churn, defined as the loss of insurance coverage causing gaps in medical access over multiple visits, emerged as a critical factor in managing chronic diseases like diabetes, which require consistent monitoring and medication adherence. According to lead author Dr. Nathalie Huguet, an associate professor at the OHSU School of Medicine, the findings highlight a direct health consequence of insurance instability, challenging the notion that coverage fluctuations are merely administrative hurdles. This insight is particularly relevant for the vulnerable populations served by community health centers, which tend to cater to individuals living near or below the poverty line.
By comparing patients who experienced insurance loss with those who maintained coverage while sharing similar clinical baselines, the research robustly demonstrated that patients undergoing churn faced worsened blood sugar control, necessitating more aggressive treatment regimes. Increased insulin utilization and deployment of other high-intensity therapies serve as red flags indicating that disrupted care ominously accelerates disease progression. The implications are disquieting, as diabetes management relies on continuity both in medication and physician contact to prevent serious and often irreversible complications.
Despite the relatively short follow-up period limiting observation of long-term consequences, the study noted no immediate rise in severe endpoints such as amputations or renal failure. However, Dr. Huguet cautions that these outcomes require longer time horizons to become manifest. The early-stage warning signals embedded in the data underscore how fragile the balance of diabetes control becomes when patients lose their safety net of insurance. It also raises complex clinical questions about how uninsured patients can feasibly manage chronic disease regimens that often necessitate costly medications and frequent adjustments.
The study amplifies previous work by Dr. Huguet that documented heightened insurance instability among low-income diabetic populations. Together, these studies illuminate a cascade effect: poverty predisposes to insurance churn, which in turn drives clinical deterioration, worsening the socioeconomic and health disparities already embedded in the US healthcare system. Moreover, these findings arrive amidst looming policy challenges, with millions of Americans facing potential Medicaid disenrollments and rising premiums projected for 2026.
Dr. Huguet emphasizes that many Medicaid recipients abruptly losing coverage confront prolonged durations without any form of insurance, while affordable alternatives on the insurance marketplace remain out of reach. This coverage gap is further compounded by exorbitant insulin prices, which remain prohibitive even for patients with partial or subsidized coverage. Although community health centers provide discounted medications, their heavy reliance on Medicaid funding means any reduction in coverage jeopardizes the sustainability of these essential services.
Co-author Dr. Jennifer DeVoe, a professor at the OHSU School of Medicine and expert in family medicine innovation, underscores the systemic challenge that arises when Medicaid support contracts. Without bolstered funding and infrastructure, primary care clinics may be ill-equipped to maintain continuity and comprehensive care for uninsured patients. Such erosion of the primary care safety net could propagate increased reliance on emergency departments, exacerbating both cost and clinical outcomes due to unmanaged chronic disease escalation.
The broader economic and healthcare implications of insurance churn-induced worsening diabetes control extend beyond individual patients. Emergency care utilization caused by gaps in insulin access and treatment adherence contributes to ballooning overall healthcare expenditures, strained institutional resources, and heightened societal burdens. The study’s findings thus advocate for policy frameworks safeguarding continuous coverage, particularly in vulnerable populations, to mitigate preventable disease exacerbation and resultant systemic costs.
Further study of insurance churn dynamics—encompassing the timing, duration, and socio-demographic correlates—remains vital to devising nuanced interventions that stabilize health insurance among patients with chronic diseases. OHSU collaborators, including data scientists and clinical epidemiologists, continue to refine analytic models integrating social determinants of health to better predict and prevent churn events. Such interdisciplinary efforts reinforce the urgency of embedding insurance stability as a cornerstone of chronic disease management.
The research was supported by a substantial financial award from the Centers for Disease Control and Prevention (CDC), reflecting national recognition of the public health importance of insurance coverage continuity. The involvement of multiple research institutions and community health networks underscores the collaborative effort necessary to address complex healthcare challenges intersecting economics, policy, and clinical care.
In summary, this groundbreaking study from Oregon Health & Science University places a spotlight on the critical intersection of insurance coverage and diabetes management among low-income populations. By evidencing the tangible health declines associated with coverage gaps, it challenges policymakers, clinicians, and public health officials to prioritize continuous insurance access as a foundational component of disease control. Without such interventions, the looming policy shifts threatening Medicaid expansion risk triggering a silent epidemic of poorly managed diabetes with far-reaching human and economic costs.
Subject of Research: People
Article Title: Insurance Churn and Diabetes Outcomes Among Patients with Low Income
News Publication Date: 20-Mar-2026
Web References:
10.1001/jamahealthforum.2026.0034
References:
Huguet, N., DeVoe, J., Dinh, D., Hwang, J., Marino, M., Larson, A., & Suchocki, A. (2026). Insurance Churn and Diabetes Outcomes Among Patients with Low Income. JAMA Health Forum. DOI:10.1001/jamahealthforum.2026.0034
Keywords:
Diabetes, Insurance, Health care costs, Health care policy, Health care delivery, Poverty
